Svennevig K, Prydz K, Kolset S O
Department of Biochemistry, University of Oslo, Norway.
Biochem J. 1995 Nov 1;311 ( Pt 3)(Pt 3):881-8. doi: 10.1042/bj3110881.
Madin-Darby canine kidney (MDCK) cells were cultured on polycarbonate filters to study the synthesis and sorting of proteoglycans in polarized epithelial cells. Two strains of MDCK cells were used. MDCK I cells resemble distal tubule epithelial cells, and MDCK II cells share some characteristics with proximal tubule cells. Both strains were grown to confluency and labelled with [35S]sulphate for 24 h. The apical and basolateral media and the cell fractions were harvested and analysed by DEAE ion-exchange chromatography. A large portion of the [35S]sulphate-labelled macromolecules bound strongly to the ion-exchange columns, and could be eluted in three distinct peaks. The latest eluting peak was demonstrated to contain almost exclusively chondroitin sulphate, whereas peak 2 contained mostly heparan sulphate, demonstrated by using chondroitinase ABC and nitrous acid (pH 1.5) respectively to depolymerize the [35S]glycosaminoglycan chains. Peak 1 contained negligible amounts of proteoglycans. Large differences could be observed in proteoglycan sorting in MDCK I and II cells. Strain I secreted approx. 67% of the proteoglycans to the apical side and 17% to the basolateral side. The cell fraction contained 17% of the proteoglycans after 24 h of labelling. In contrast, 19% of the proteoglycans were sorted to the apical side of MDCK II cells and 61% to the basolateral side, whereas the cell fraction contained 20%. Furthermore, the level of [35S]proteoglycan biosynthesis (apical and basolateral media and cell fraction total) was higher in MDCK I cells than in strain II. Based on the amount of material degraded by chondroitinase ABC and nitrous acid respectively, and the total amounts of [35S]proteoglycans recovered from the cells, it was calculated that the MDCK I strain synthesized approx. 56% chondroitin sulphate and 44% heparan sulphate. In contrast, the MDCK II strain synthesized 69% heparan sulphate and 31% chondroitin sulphate. To further identify the [35S]proteoglycans synthesized by MDCK I and II cells, antibodies against perlecan, versican and syndecan were used. The antibody against mouse syndecan did not cross-react with any of the proteoglycans produced in MDCK I or II cells. Both MDCK I and II cells expressed perlecan; 57-61% could be recovered from the basolateral fractions and 18-34% from the apical medium. Versican was also found in both MDCK I and II cells. Compared with perlecan, a larger percentage of versican (43-53%) was found in the cell fractions.
将Madin-Darby犬肾(MDCK)细胞培养在聚碳酸酯滤膜上,以研究极化上皮细胞中蛋白聚糖的合成与分选。使用了两株MDCK细胞。MDCK I细胞类似于远端肾小管上皮细胞,而MDCK II细胞与近端肾小管细胞有一些共同特征。将两株细胞培养至汇合状态,并用[35S]硫酸盐标记24小时。收集顶端和基底外侧培养基以及细胞组分,通过DEAE离子交换色谱法进行分析。大部分[35S]硫酸盐标记的大分子与离子交换柱强烈结合,并可在三个不同的峰中洗脱。最后洗脱的峰几乎只含有硫酸软骨素,而峰2主要含有硫酸乙酰肝素,分别使用软骨素酶ABC和亚硝酸(pH 1.5)使[35S]糖胺聚糖链解聚来证明。峰1含有可忽略不计的蛋白聚糖量。在MDCK I和II细胞的蛋白聚糖分选方面可观察到很大差异。I株细胞将约67%的蛋白聚糖分泌到顶端侧,17%分泌到基底外侧侧。标记24小时后,细胞组分中含有17%的蛋白聚糖。相比之下,19%的蛋白聚糖被分选到MDCK II细胞的顶端侧,61%分选到基底外侧侧,而细胞组分中含有20%。此外,MDCK I细胞中[35S]蛋白聚糖的生物合成水平(顶端和基底外侧培养基以及细胞组分总量)高于II株细胞。根据分别被软骨素酶ABC和亚硝酸降解的物质的量以及从细胞中回收的[35S]蛋白聚糖的总量计算得出,MDCK I株细胞合成了约56%的硫酸软骨素和44%的硫酸乙酰肝素。相比之下,MDCK II株细胞合成了69%的硫酸乙酰肝素和31%的硫酸软骨素。为了进一步鉴定MDCK I和II细胞合成的[35S]蛋白聚糖,使用了针对基底膜聚糖、多功能蛋白聚糖和多配体蛋白聚糖的抗体。抗小鼠多配体蛋白聚糖的抗体与MDCK I或II细胞产生的任何蛋白聚糖均无交叉反应。MDCK I和II细胞均表达基底膜聚糖;57 - 61%可从基底外侧组分中回收,18 - 34%可从顶端培养基中回收。在MDCK I和II细胞中也发现了多功能蛋白聚糖。与基底膜聚糖相比,多功能蛋白聚糖在细胞组分中的比例更大(43 - 53%)。